EVAXION BIOTECH A S's ticker is EVAX and the CUSIP is 29970R105. A total of 11 filers reported holding EVAXION BIOTECH A S in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,646 | -69.9% | 43,774 | -54.5% | 0.00% | – |
| Q2 2023 | $125,081 | -6.8% | 96,216 | -19.0% | 0.00% | – |
| Q1 2023 | $134,156 | +79.2% | 118,722 | +185.4% | 0.00% | – |
| Q4 2022 | $74,880 | -90.7% | 41,600 | -86.4% | 0.00% | – |
| Q3 2022 | $803,000 | +113.6% | 305,200 | +58.3% | 0.00% | – |
| Q2 2022 | $376,000 | +6.5% | 192,800 | +66.5% | 0.00% | – |
| Q1 2022 | $353,000 | +42.3% | 115,800 | +107.6% | 0.00% | – |
| Q4 2021 | $248,000 | – | 55,780 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ground Swell Capital, LLC | 18,071 | $32,528 | 0.14% |
| Telemetry Investments, L.L.C. | 37,500 | $68 | 0.11% |
| Beacon Capital Management, LLC | 6,881 | $12,214 | 0.00% |
| PURA VIDA INVESTMENTS, LLC | 16,842 | $29,895 | 0.00% |
| MORGAN STANLEY | 3,696 | $6,560 | 0.00% |
| Citadel Advisors | 13,000 | $23,400 | 0.00% |
| Citadel Advisors | 500 | $900 | 0.00% |
| Citadel Advisors | 1,485 | $2,673 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 41,600 | $74,880 | 0.00% |
| UBS Group AG | 5,081 | $9,044 | 0.00% |